COVID-19 Vaccine In India- The Current Developments

The dry run of the coronavirus vaccine began as of 5th January 2021 at 259 sites spread across 116 districts in all states and union territories. Union Health Minister Harsh Vardhan said that the Covid-19 vaccines would be provided free of cost to everyone in the country. There are 2 major vaccine producers in limelight with vaccines for the COVID-19 virus namely Covaxin and Covishield. Covishield distribution has started as they are approved by DCGI since they have passed all the necessary tests. Covaxin is under final trials for approval from DCGI.

Current Developments.
Bharat Biotech has announced successful recruitment of 23,000 volunteers and continued progress towards achieving the goal of 26,000 participants for the Phase-3 clinical trial of COVAXIN across multiple sites in India. As soon as the trials end the validity of the vaccine will be made public and so will be the decision whether this vaccine will be distributed or not.

Akhilesh Yadav took on Twitter and tweeted a tweet in Hindi that said, “We have full faith in the efficiency of scientists but do not trust the unscientific thinking of the BJP and the medical arrangements of the BJP government administering vaccines which had been lying almost inactive during the corona times.” “We will not take the political vaccine of the BJP. The SP government will provide free vaccines,”.

As India inches closer towards kicking off the Covid-19 vaccination drive, syringe makers have been hard at work to ramp up production capabilities. The vaccines will require syringes and mass orders are expected to fulfill the distribution of the vaccine across India as fast as possible.

Both the vaccines are expected to be available for restricted and emergency uses with non-observed side effects which were one of the main concerns of the DGCI.

Over to you.
India is accelerating its vaccine production and distribution with 2 viable vaccines namely, Covaxin and Covishield. The vaccine is expected to have no side effects and is also expected to be distributed across India as fast as possible, for the said reason major syringe orders are also supposedly given for distribution purposes.